Trials / Completed
CompletedNCT01529359
Irritable Bowel Syndrome and Lactibiane Tolerance
Effect of Lactibiane Tolerance on Symptoms Severity of Irritable Bowel Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- PiLeJe · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effects of a probiotic combination (Lactibiane Tolerance) on the severity of symptoms in patients with irritable bowel syndrome (IBS).
Detailed description
The primary purpose of this study is to evaluate the effects of a probiotic combination (Lactibiane Tolerance) on the severity of symptoms in patients with irritable bowel syndrome (IBS). The secondary purposes are to evaluate the effects of the intervention on: * quality of life * severity of fatigue, anxiety and depression * levels of inflammatory markers in blood and tools
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactibiane Tolerance | Probiotics combination 2 gelules per days during 6 weeks |
| DIETARY_SUPPLEMENT | Placebo | Placebo 2 gelules per days for 6 weeks |
Timeline
- Start date
- 2010-03-24
- Primary completion
- 2013-02-04
- Completion
- 2013-02-11
- First posted
- 2012-02-08
- Last updated
- 2021-04-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01529359. Inclusion in this directory is not an endorsement.